Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Anthem : Wells Fargo Adjusts Anthem's Price Target to $500 From $460, Maintains Overweight Rating

10/25/2021 | 08:21am EST


ę MT Newswires 2021
All news about ANTHEM, INC.
01/12Anthem to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January..
BU
01/06Wells Fargo Adjusts Anthem Price Target to $523 From $500, Maintains Overweight Rating
MT
01/05Truist Adjusts Price Target on Anthem to $540 From $490, Maintains Buy Rating
MT
01/05Castlight Health, Vera Whole Health to Merge in $370 Million Deal
MT
01/05Credit Suisse Raises Outperform-Rated Anthem's Price Target to $518 from $486, Remains ..
MT
01/05Castlight Health to Be Acquired by CD&R's Vera for $370 Million
DJ
2021Today on Wall Street: Bad timing
2021ANALYST RECOMMENDATIONS : Anthem, AT&T, Block, Fedex, Visa...
2021Mizuho Securities Upgrades Anthem to Buy From Neutral, Adjusts Price Target to $510 Fro..
MT
2021Chinese spies have penetrated Taiwan's military, case documents reveal
RE
More news
Analyst Recommendations on ANTHEM, INC.
More recommendations
Financials (USD)
Sales 2021 138 B - -
Net income 2021 6 116 M - -
Net Debt 2021 16 475 M - -
P/E ratio 2021 18,2x
Yield 2021 0,99%
Capitalization 110 B 110 B -
EV / Sales 2021 0,92x
EV / Sales 2022 0,82x
Nbr of Employees 83 400
Free-Float -
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | ANTM | US0367521038 | MarketScreener
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 452,14 $
Average target price 482,09 $
Spread / Average Target 6,62%
EPS Revisions
Managers and Directors
Gail Koziara Boudreaux President, Chief Executive Officer & Director
John Edward Gallina Chief Financial Officer & Executive Vice President
Elizabeth E. Tallett Independent Chairman
Dustin Wilcox VP & Chief Information Security Officer
Gloria M. McCarthy Chief Administrative Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.-2.46%109 741
UNITEDHEALTH GROUP-6.66%441 436
CIGNA CORPORATION5.46%80 262
HUMANA INC.-15.57%50 342
CENTENE CORPORATION-2.25%47 001
MOLINA HEALTHCARE, INC.-10.05%16 708